Lannett Receives FDA Approval for HCTZ 12.5mg Capsules

Lannett announced that the FDA has approved its Abbreviated New Drug Application (ANDA) for Hydrochlorothiazide capsules, 12.5mg, a generic equivalent  of Watson's Microzide capsules. Hydrochlorothiazide is indicated for the management of hypertension.

 For more information, call (215) 333-9000 or visit www.lannett.com.